Urology Search
Urology Urology
renal%20cancer
RENAL CANCER

Renal cancer is the disease in which certain tissues of the kidney starts to grow uncontrollably and form a tumor.

It is also called as renal adenocarcinoma or hypernephroma.

Classic triad of symptoms are flank pain, palpable abdominal mass and gross hematuria.

Introduction

  • Also known as renal adenocarcinoma or hypernephroma

Definition

  • Disease in w/c the cells in certain tissues of the kidney start to grow uncontrollably & form a tumor

Signs and Symptoms

  • Classic triad of symptoms:
    • Flank pain
    • Palpable abdominal mass
    • Gross hematuria

Other symptoms

  • Anemia
  • Fever
  • Hepatic dysfunction
  • Loss of appetite
  • Malaise
  • Night sweats
  • Weight loss
  • Varicocele

Risk Factors

  • Ages between 50-70 years old
  • Men are 2-3 times more likely to develop kidney cancer than women
  • Chronic hepatitis C infection
  • Chronic kidney disease or in long-term dialysis
  • Exposure to cadmium & asbestos
  • Family history of kidney cancer & hereditary diseases (eg von Hippel-Lindau, hereditary papillary renal carcinoma, Birt-Hogg-Dubé syndrome, tuberous sclerosis complex
  • Africans have higher rates than Americans
  • High blood pressure
  • Obesity
  • Overuse of medications such as Aspirin, Paracetamol & Ibuprofen
  • Polycystic kidney disease
  • Tobacco smoking
Editor's Recommendations
Most Read Articles
Strong belief in medication necessity tied to better adherence in RA patients
4 days ago
A strong belief in the necessity of medication is associated with better adherence to oral disease-modifying antirheumatic drugs (DMARDs) or prednisone, while higher self-efficacy correlates with poor adherence, in a diverse cohort of patients with rheumatoid arthritis (RA), suggests a study.
Low-dose haloperidol ineffective against delirium following thoracic surgery
3 days ago
Low-dose administrations of haloperidol after thoracic surgery does not appear to prevent postoperative delirium, according to a new study.
PCI vs CABG shows similar rates of mortality but higher target-vessel revascularizations at 10 years
Yesterday
Percutaneous coronary intervention (PCI) displays comparable rates of mortality and serious composite outcomes but a higher rate of target-vessel revascularization at 10 years relative to coronary artery bypass grafting (CABG) in patients with significant left main coronary artery (LMCA) disease, reports a study. On the other hand, CABG delivers lower mortality and serious composite outcome rates compared with PCI with drug-eluting stents after 5 years.
Apixaban trumps standard treatment in preventing cancer-associated VTE recurrence
Pearl Toh, 2 days ago
Apixaban slashes the risk of recurrent venous thromboembolism (VTE) by 90 percent in cancer patients compared with the low-molecular-weight heparin (LMWH) dalteparin, with no increase in major bleeding risk, according to the ADAM VTE study presented at ASH 2018.